Roche deal latest in AAV gene therapy partnership plan for Dyno
US company, Dyno Therapeutics, has inked a deal with Roche to develop next-generation AAV gene therapy vectors for central nervous system (CNS) diseases and liver-directed therapies.
Archives for October 19, 2020
Moderna COVID-19 vaccine under rolling review process in Canada, EU
Moderna is engaging with international regulators to accelerate approval of its COVID-19 vaccine candidate.
Edesa Biotech gets green light for COVID-19 monoclonal antibody study in the US
Edesa Biotech, Inc. has received clearance from the U.S. Food and Drug Administration (FDA) to begin the Phase 2 portion of its Phase 2/3 clinical study of its investigational drug, EB05, for the treatment of hospitalized COVID-19 patients.